Home Renal Dialysis Machine Offers Patients More Freedom
|
By HospiMedica International staff writers Posted on 18 May 2009 |
A new home dialysis machine helps patients with kidney failure and end stage renal disease (ESRD) self-administer peritoneal dialysis at home while they sleep.
The Liberty Cycler is intended for use in automated peritoneal dialysis (APD) therapy, regulating the exchange of used and fresh dialysis fluid while the patient sleeps; but unlike hemodialysis, the Liberty does not require needles. The Liberty Cycler fills and empties the abdomen with dialysate three to five times at night during sleep; in the morning, dialysate flows into the abdomen, and the catheter is detached from the system. The dialysate is carried in the peritoneal cavity during the day. During that time, normal daily activities can be maintained. At night, the catheter is reattached to the cycler before sleep, to perform APD one again.
The Liberty Cycler features a large color touch screen that gives easy to follow directions accompanied by pictures, an easy-to-load APD treatment cassette, and special connectors that are automatically inserted into the catheter lumen, making it easy to perform dialysate exchanges. The Liberty Cycler has a small footprint, small enough to fit on a nightstand, and requires no special plumbing or electrical hook-ups. The Liberty Cycler is available only through the dialysis facilities of the developer Fresenius Medical Care (Bad Homburg, Germany).
"Fresenius Medical Care recognizes that many dialysis patients have active lifestyles, and want more choices for treatment,” said Michael Lazarus, M.D., chief medical officer and senior executive VP of Fresenius Medical Care North America. "Many patients have discovered that dialyzing while they sleep provides them with the freedom to continue to pursue their careers, care for their families, or enjoy their years of retirement.”
The fluids used in APD contain either a glucose and amino acid solution or a compound called icodextrin to remove water from the patients blood, with the glucose solution most commonly used. The glucose "strength” (1.5%, 2.5% or 4.25%) of the solution determines how much water is removed--the higher the concentration, the greater the effect. The amino acids in the solution are used to improve the patient's nutritional condition. The benefits of the icodextrin fluid, on the other hand, are that it removes more water than the glucose solution for longer exchange intervals, and that it is glucose- free, which is advantageous both for the peritoneum and the body as a whole.
Related Links:
Fresenius Medical Care
The Liberty Cycler is intended for use in automated peritoneal dialysis (APD) therapy, regulating the exchange of used and fresh dialysis fluid while the patient sleeps; but unlike hemodialysis, the Liberty does not require needles. The Liberty Cycler fills and empties the abdomen with dialysate three to five times at night during sleep; in the morning, dialysate flows into the abdomen, and the catheter is detached from the system. The dialysate is carried in the peritoneal cavity during the day. During that time, normal daily activities can be maintained. At night, the catheter is reattached to the cycler before sleep, to perform APD one again.
The Liberty Cycler features a large color touch screen that gives easy to follow directions accompanied by pictures, an easy-to-load APD treatment cassette, and special connectors that are automatically inserted into the catheter lumen, making it easy to perform dialysate exchanges. The Liberty Cycler has a small footprint, small enough to fit on a nightstand, and requires no special plumbing or electrical hook-ups. The Liberty Cycler is available only through the dialysis facilities of the developer Fresenius Medical Care (Bad Homburg, Germany).
"Fresenius Medical Care recognizes that many dialysis patients have active lifestyles, and want more choices for treatment,” said Michael Lazarus, M.D., chief medical officer and senior executive VP of Fresenius Medical Care North America. "Many patients have discovered that dialyzing while they sleep provides them with the freedom to continue to pursue their careers, care for their families, or enjoy their years of retirement.”
The fluids used in APD contain either a glucose and amino acid solution or a compound called icodextrin to remove water from the patients blood, with the glucose solution most commonly used. The glucose "strength” (1.5%, 2.5% or 4.25%) of the solution determines how much water is removed--the higher the concentration, the greater the effect. The amino acids in the solution are used to improve the patient's nutritional condition. The benefits of the icodextrin fluid, on the other hand, are that it removes more water than the glucose solution for longer exchange intervals, and that it is glucose- free, which is advantageous both for the peritoneum and the body as a whole.
Related Links:
Fresenius Medical Care
Latest Critical Care News
- Whole-Heart Mapping Technology Provides Comprehensive Real-Time View of Arrhythmias
- Wearable Device for Diabetics Could Replace Continuous Glucose Monitoring Systems
- AI Stethoscope Spots Heart Valve Disease Earlier Than GPs
- Bioadhesive Patch Eliminates Cancer Cells That Remain After Brain Tumor Surgery
- Wearable Patch Provides Up-To-The-Minute Readouts of Medication Levels in Body
- New Spray-Mist Device Delivers Antibiotics Directly into Infected Tissue
- Living Implant Could End Daily Insulin Injections
- Intelligent Camera System Continuously Monitors Premature Babies in NICU
- Intranasal Spray to Prevent Illnesses from Respiratory Viruses
- Gut Bacteria from Amphibians and Reptiles Show Complete Tumor Elimination
- High-Dose Inhaled Nitric Oxide Emerges as Promising Antimicrobial Therapy
- AI Risk Prediction Tool Improves Treatment of Cancer Patients after Heart Attack
- Glowing Bacterial Sensors Could Improve Detection of Gut Illness
- Innovative ‘Poop Pills’ Dramatically Improve Cancer Treatment

- New Nanomaterial Kills Cancer Cells While Sparring Healthy Tissues
- AI Model Accurately Predicts Neurological Recovery After Cardiac Arrest
Channels
Artificial Intelligence
view channelSurgical Techniques
view channelAI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries
Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more
Neural Device Regrows Surrounding Skull After Brain Implantation
Placing electronic implants on the brain typically requires removing a portion of the skull, creating challenges for long-term access and safe closure. Current methods often involve temporarily replacing... Read morePatient Care
view channel
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
VR Training Tool Combats Contamination of Portable Medical Equipment
Healthcare-associated infections (HAIs) impact one in every 31 patients, cause nearly 100,000 deaths each year, and cost USD 28.4 billion in direct medical expenses. Notably, up to 75% of these infections... Read more
Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read moreFirst-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read moreHealth IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read moreBusiness
view channel
Medtronic to Acquire Coronary Artery Medtech Company CathWorks
Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Medtronic and Mindray Expand Strategic Partnership to Ambulatory Surgery Centers in the U.S.
Mindray North America and Medtronic have expanded their strategic partnership to bring integrated patient monitoring solutions to ambulatory surgery centers across the United States. The collaboration... Read more
FDA Clearance Expands Robotic Options for Minimally Invasive Heart Surgery
Cardiovascular disease remains the world’s leading cause of death, with nearly 18 million fatalities each year, and more than two million patients undergo open-heart surgery annually, most involving sternotomy.... Read more







